Wave Life Sciences (WVE) Total Current Liabilities (2014 - 2026)
Wave Life Sciences (WVE) posted Total Current Liabilities of $49.8 million for Q1 2026, down 47.58% on a QoQ basis from $95.1 million in Q4 2025, and down 42.96% year-over-year from $87.4 million in Q1 2025.
Wave Life Sciences (WVE) Total Current Liabilities (2014 - 2026) Analysis & Trends
Wave Life Sciences' Total Current Liabilities history runs 13 years deep, the most recent figure standing at $49.8 million for Q1 2026.
- Quarterly Total Current Liabilities fell 42.96% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (down 42.96% YoY) and the FY2025 annual result came in at $95.1 million, down 14.32% from the prior year.
- Total Current Liabilities was $49.8 million for Q1 2026 at Wave Life Sciences, down from $95.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $186.4 million in Q4 2023 and bottomed at $49.8 million in Q1 2026.
- A 5-year average of $108.5 million and a median of $95.1 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 160.68% — and 2025, when it sank 49.69%.
- Wave Life Sciences' Total Current Liabilities stood at $71.5 million in 2022, then jumped by 160.68% to $186.4 million in 2023, then slumped by 40.49% to $111.0 million in 2024, then declined by 14.32% to $95.1 million in 2025, then slumped by 47.58% to $49.8 million in 2026.
- Business Quant data shows WVE's Total Current Liabilities at $49.8 million in Q1 2026, $95.1 million in Q4 2025, and $85.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 49.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.83 Mn |
| Dec 31, 2025 | 95.07 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Jun 30, 2025 | 87.41 Mn |
| Mar 31, 2025 | 87.37 Mn |
| Dec 31, 2024 | 110.95 Mn |
| Sep 30, 2024 | 170.73 Mn |
| Jun 30, 2024 | 173.13 Mn |
| Mar 31, 2024 | 165.87 Mn |
| Dec 31, 2023 | 186.44 Mn |
| Sep 30, 2023 | 99.98 Mn |
| Jun 30, 2023 | 140.23 Mn |
| Mar 31, 2023 | 132.57 Mn |
| Dec 31, 2022 | 71.52 Mn |
| Sep 30, 2022 | 64.26 Mn |
| Jun 30, 2022 | 64.08 Mn |
| Mar 31, 2022 | 58.49 Mn |
| Dec 31, 2021 | 64.20 Mn |
| Sep 30, 2021 | 31.64 Mn |
| Jun 30, 2021 | 46.72 Mn |